COVX
Covx is a biotechnology company. It engages in the discovery and development of long-acting biological therapies called CovX-Bodies. Its products pipeline focuses on targets that inhibit tumor angiogenesis and modulate metabolic disorders. Their products pipeline includes CVX-045, a thrombospondin-1 mimetic CovX-Body; TSP-1, a negative regulator of angiogenesis that acts as a therapeutic target in oncology; CVX-060, a selective angiopoietin-2 antagonist COVX-BODY; and CVX-096, a long-acting GLP-1 mimetic COVX-BODY. Covx was founded by Carlos Barbas in 2002 and is headquartered in San Diego, California.
COVX
Industry:
Biotechnology Medical
Founded:
2002-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.covx.com
Status:
Active
Contact:
858-964-2000
Technology used in webpage:
Akamai Hosted MarkMonitor DNS MarkMonitor
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Founder
